Carfentanil and the Rise and Fall of Overdose Deaths in the United States

Overview

Journal Addiction

Specialty Psychiatry

Date 2020 Sep 16

PMID 32935381

Citations 23

Authors

Hawre Jalal

Donald S Burke

Affiliations

Soon will be listed here.

Abstract

Background And Aims: It is widely believed that the 2018 decline in overdose deaths in the United States was attributable to a range of public health interventions, however, this decline also coincided with the regulation and decline in use of potent fentanyl analogs, especially carfentanil. The aim of this study was to investigate the association between overdose deaths and carfentanil availability in the United States.

Design: Secondary analysis of drug overdose deaths from the Center for Disease Control and Prevention (CDC) and carfentanil exhibit data from drug seizures submitted to drug crime labs and published by the Drug Enforcement Administration (DEA). Trends in overdose deaths were compared in states with high carfentanil exhibits with states with low or no carfentanil exhibits.

Setting: United States.

Participants: A total of 1 035 923 drug overdose death records in the United States from 1979 through 2019 were studied.

Measurements: The outcomes studied were number of overdose deaths and mortality rates by state.

Findings: Drug overdose deaths have been closely tracked along an exponential curve. The years 2016 and 2017 witnessed a hyper-exponential surge with increases in overdose deaths of 11 228 (+21.4%) and 6605 (+10.4%), respectively. Subsequently in 2018, drug overdose deaths declined by -2870 (-4.1%). This rise and then fall coincided with a surge and then decline in carfentanil drug seizure exhibits during these same years: 0 (2015), 1292 (2016), 5857 (2017) and 804 (2018). The majority of carfentanil exhibits were localized to a few states. The 2018 decline in overdose deaths in the top five states with the greatest spike in carfentanil exhibits in 2017 (Ohio, Florida, Pennsylvania, Kentucky and Michigan) was 2848, which accounted for nearly all of the total US decline.

Conclusions: The 2016-2017 acceleration and then 2018 decline in drug overdose deaths in the United States was associated with the sudden rise and then fall of carfentanil availability. Given the regional variation, carfentanil's decreased availability may have contributed to the reduction in overdose deaths in 2018.

Citing Articles

From Veterinary Medicine to Illicit Drug Supply: Utilising Social Media to Explore the Rising Emergence of Veterinary Medicines in Human Health.

Dunn J, Schifano F, Dudley E, Arillotta D, Guirguis A Brain Sci. 2025; 15(2).

PMID: 40002505 PMC: 11852530. DOI: 10.3390/brainsci15020172.

An analysis of the size of law enforcement seizures of illicit fentanyl in the United States, 2018-2023.

Palamar J, Fitzgerald N, Carr T Drug Alcohol Rev. 2025; 44(3):793-798.

PMID: 39967034 PMC: 11901355. DOI: 10.1111/dar.14022.

The development of opioid vaccines as a novel strategy for the treatment of opioid use disorder and overdose prevention.

Tuncturk M, Kushwaha S, Heider R, Heider BS R, Oesterle T, Weinshilboum R Int J Neuropsychopharmacol. 2025; 28(2).

PMID: 39831679 PMC: 11792077. DOI: 10.1093/ijnp/pyaf005.

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration's Adverse Events Reporting System (FAERS).

Dunn J, Schifano F, Dudley E, Guirguis A Toxics. 2024; 12(11).

PMID: 39590957 PMC: 11597946. DOI: 10.3390/toxics12110777.

Enhancing Outcomes in Opioid Use Disorder Treatment: An Economic Evaluation of Improving Medication Adherence for Buprenorphine Through Blister-Packaging.

Borrelli E, Saad P, Barnes N, Nelkin H, Dumitru D, Lucaci J Subst Abuse Rehabil. 2024; 15:209-222.

PMID: 39463862 PMC: 11512561. DOI: 10.2147/SAR.S484831.

References

Rosenblum D, Unick J, Ciccarone D . The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs. Drug Alcohol Depend. 2020; 208:107779. PMC: 7096152. DOI: 10.1016/j.drugalcdep.2019.107779. View

Becker W, Fiellin D . When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Ann Intern Med. 2020; 173(1):59-60. PMC: 7138333. DOI: 10.7326/M20-1210. View

Kreek M, Reed B, Butelman E . Current status of opioid addiction treatment and related preclinical research. Sci Adv. 2019; 5(10):eaax9140. PMC: 6774730. DOI: 10.1126/sciadv.aax9140. View

Zibbell J, Aldridge A, Cauchon D, Defiore-Hyrmer J, Conway K . Association of Law Enforcement Seizures of Heroin, Fentanyl, and Carfentanil With Opioid Overdose Deaths in Ohio, 2014-2017. JAMA Netw Open. 2019; 2(11):e1914666. PMC: 6902770. DOI: 10.1001/jamanetworkopen.2019.14666. View

Compton W, Jones C, Baldwin G . Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med. 2016; 374(2):154-63. PMC: 11784537. DOI: 10.1056/NEJMra1508490. View

Sohn M, Talbert J, Huang Z, Lofwall M, Freeman P . Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States. JAMA Netw Open. 2019; 2(6):e196215. PMC: 6593960. DOI: 10.1001/jamanetworkopen.2019.6215. View

Freeman P, Hankosky E, Lofwall M, Talbert J . The changing landscape of naloxone availability in the United States, 2011 - 2017. Drug Alcohol Depend. 2018; 191:361-364. PMC: 6167017. DOI: 10.1016/j.drugalcdep.2018.07.017. View

Ciccarone D . The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019; 71:183-188. PMC: 6675668. DOI: 10.1016/j.drugpo.2019.01.010. View

Young A, Havens J . Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction. 2011; 107(3):587-96. PMC: 3262084. DOI: 10.1111/j.1360-0443.2011.03635.x. View

10.

Alexander G, Stoller K, Haffajee R, Saloner B . An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Ann Intern Med. 2020; 173(1):57-58. PMC: 7138407. DOI: 10.7326/M20-1141. View

11.

Jalal H, Buchanich J, Roberts M, Balmert L, Zhang K, Burke D . Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018; 361(6408). PMC: 8025225. DOI: 10.1126/science.aau1184. View

12.

King A, Foley D, Arfken C, Aaron C, Sung L, Hlavaty L . Carfentanil-Associated Mortality in Wayne County, Michigan, 2015-2017. Am J Public Health. 2018; 109(2):300-302. PMC: 6336071. DOI: 10.2105/AJPH.2018.304814. View

13.

Volkow N . Collision of the COVID-19 and Addiction Epidemics. Ann Intern Med. 2020; 173(1):61-62. PMC: 7138334. DOI: 10.7326/M20-1212. View

14.

Hedegaard H, Bastian B, Trinidad J, Spencer M, Warner M . Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016. Natl Vital Stat Rep. 2019; 67(9):1-14. View